Inspire Medical Systems Inc (INSP)
Official siteHEALTHCARE • MEDICAL DEVICES • NYSE
Market Cap: $1.71B
Last updated: Nov 17, 2026 at 4:17 PM ET
Inspire Medical Systems Inc (INSP) Stock Chart
Inspire Medical Systems (INSP) has a latest price of $59.44 on Nov 17, 2026, 59.6% below its 52-week high of $147.03. Its price fell 31.2% over the past 12 months. The month-end price rose 127.0% since May 2018, a compound annual rate of 10.2%.
Price Chart
From May 2018 to Oct 2026, its highest month-end close was $324.64 in Jun 2023 and its lowest $30.00 in May 2018, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart INSP with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for INSP.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 3.7%, and over 6 months it rose 39.7%. The month-end price fell 53.7% over the 3 years through Oct 2026, a compound annual decline of 22.7%.
| Period | Change |
|---|---|
| 1 month | -15.3% |
| 3 months | -3.7% |
| 6 months | +39.7% |
| 12 months | -31.2% |
| 12 months, with dividends | -31.2% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -53.7% | -22.7% |
| 5 years | -74.7% | -24.1% |
| Since May 2018 | +127.0% | +10.2% |
Price by Year
Its best calendar year was 2020, when the price rose 153.5%, and its weakest was 2025, when it fell 50.2%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $68.10 | -26.2% |
| 2025 | $92.23 | -50.2% |
| 2024 | $185.38 | -8.9% |
| 2023 | $203.43 | -19.2% |
| 2022 | $251.88 | +9.5% |
| 2021 | $230.06 | +22.3% |
| 2020 | $188.09 | +153.5% |
| 2019 | $74.21 | +75.6% |
Trading Range
The price is 13.6% below its 50-day average of $68.82 and 3.7% above its 200-day average of $57.29.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $59.44 | |
| 52-week high | $147.03 | -59.6% |
| 52-week low | $38.91 | +52.7% |
| 50-day average | $68.82 | -13.6% |
| 200-day average | $57.29 | +3.7% |
Price Risk
Over 3 years, its largest fall from a peak was 84.1%.
| Measure | Value |
|---|---|
| 1-year beta | 0.92 |
| Largest fall, 1 year | -72.2% |
| Largest fall, 3 years | -84.1% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About INSP
What is INSP's 1-year price change?
Inspire Medical Systems's price fell 31.2% over the past 12 months. With dividends included, the 12-month total return was -31.2%.
What is INSP's 5-year price change?
Inspire Medical Systems's month-end price fell 74.7% over the 5 years through Oct 2026, a compound annual decline of 24.1%. These figures leave out dividends.
What is INSP's 52-week high and low?
Inspire Medical Systems's 52-week high is $147.03 and its 52-week low is $38.91. Its latest price of $59.44 on Nov 17, 2026 is 59.6% below the high.
What is INSP's beta?
Inspire Medical Systems's 1-year beta against the S&P 500 is 0.92, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 72.2%.
Is the INSP chart free?
Yes. Advanced Charting for INSP is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
INSP pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts